Cargando…
The Potential of Probiotics to Eradicate Gut Carriage of Pathogenic or Antimicrobial-Resistant Enterobacterales
Probiotic supplements have been used to decrease the gut carriage of antimicrobial-resistant Enterobacterales through changes in the microbiota and metabolomes, nutrition competition, and the secretion of antimicrobial proteins. Many probiotics have shown Enterobacterales-inhibiting effects ex vivo...
Autores principales: | Hung, Yuan-Pin, Lee, Ching-Chi, Lee, Jen-Chieh, Tsai, Pei-Jane, Hsueh, Po-Ren, Ko, Wen-Chien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470257/ https://www.ncbi.nlm.nih.gov/pubmed/34572668 http://dx.doi.org/10.3390/antibiotics10091086 |
Ejemplares similares
-
Gut Dysbiosis during COVID-19 and Potential Effect of Probiotics
por: Hung, Yuan-Pin, et al.
Publicado: (2021) -
Risk Factors and Clinical Impact of Carbapenem-Resistant Enterobacterales Coinfections Among Hospitalized Patients with Clostridioides difficile Infection
por: Lee, Ching-Chi, et al.
Publicado: (2022) -
Application of Microbiome Management in Therapy for Clostridioides difficile Infections: From Fecal Microbiota Transplantation to Probiotics to Microbiota-Preserving Antimicrobial Agents
por: Chiu, Chun-Wei, et al.
Publicado: (2021) -
Nationwide surveillance of ribotypes and antimicrobial susceptibilities of toxigenic Clostridium difficile isolates with an emphasis on reduced doxycycline and tigecycline susceptibilities among ribotype 078 lineage isolates in Taiwan
por: Hung, Yuan-Pin, et al.
Publicado: (2018) -
A brief on new waves of monkeypox and vaccines and antiviral drugs for monkeypox
por: Hung, Yuan-Pin, et al.
Publicado: (2022)